Health Care System For Aging Nerve Cells

Main Category: Parkinson's Disease
Also Included In: Neurology / Neuroscience;  Seniors / Aging;  Biology / Biochemistry
Article Date: 19 Mar 2007 - 8:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (5 votes)

Healthcare Prof:2 and a half stars

2.5 (2 votes)


In mice the researchers inactivated the receptors of two neurotrophic factors in the substantia nigra, an area in which early cell death gives rise to Parkinson disease. The brains of these mice developed normally, however in the adult animal a significant decrease of dopaminergic neurons was observed over time, similar to what is seen in patients suffering form Parkinson disease. (PLoS Biology, March 5, 2007).

Parkinson patients suffer from loss of dopaminergic neurons in a certain region of the brain, the substantia nigra. Several experiments seem to indicate that the neurotrophic factor GDNF and its receptor might prevent an early, uncontrolled death of these neurons. The international team consisting of Edgar Kramer, Liviu Aron, Sabine Seitz und Rüdiger Klein of the Max Planck Institute of Neurobiology has now shown that neurons of the substantia nigra lacking the Ret-receptor indeed suffer an earlier death compared to normal control neurons. Loss of nerve cells and axons in this brain region is typical for Parkinson disease.

The disappearance of neurons lacking the Ret-receptor in this brain area has now for the first time been observed in mice, since the scientists were able to eliminate the receptor specifically in neurons of this brain region. The mice thus altered are viable and live as long as their normal relatives. "For the first time it was now possible to study the effects of missing GDNF signals on the establishment and maintenance of the nigrostriatal pathway (a neural pathway connecting the substantia nigra with the striatum)", stated Rüdiger Klein, Director at the Max Planck Institute of Neurobiology and head of the research team. Animals that lack GDNF and its receptor in all neurons are not viable and therefore it was not possible to investigate the precise role of GDNF and its receptor in the adult and aging brain.

"Surprisingly even without the Ret- receptor the nigrostriatal system developed normally", remarked Edgar Kramer, one of the leading scientists of the study. Only in adulthood the inability of these neurons to receive GDNF due to the missing receptor became evident and the older the animals grew, the more nerve cells died.

Worldwide more than 100 million especially older people suffer from diseases of the brain that are characterized by a gradual loss of neurons. Depending on which region of the brain is affected the symptoms vary, e.g. Alzheimer patients suffer from a progressive loss of memory whereas in Parkinson disease failures of the motor system are most evident. However, the characteristic muscle shaking and the inability to initiate movement of Parkinson's disease, from which also prominent people like Muhammed Ali and Michael J. Fox suffer, only become apparent after more than 50 percent of the neurons have died.

"Our results will help us to understand which factors nerve cells fated to die in Parkinson's patients need to survive" Rüdiger Klein stated. The published results are therefore of importance for promoting therapeutic approaches against Parkinson's disease.

###

Contact: Rüdiger Klein
Max-Planck-Gesellschaft

Article adapted by Medical News Today from original press release.
Visit our parkinson's disease section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Rüdiger Klein. "Health Care System For Aging Nerve Cells." Medical News Today. MediLexicon, Intl., 19 Mar. 2007. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/65230.php>

APA
Rüdiger Klein. (2007, March 19). "Health Care System For Aging Nerve Cells." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/65230.php.

Please note: If no author information is provided, the source is cited instead.


Parkinson's Disease

What is Parkinson's Disease?

Parkinson's disease is a gradually progressive, degenerative neurologic disorder which typically impairs the patient's motor skills, speech, writing, as well as some other functions. Read more...

Most Popular Articles



Follow Our Parkinson's Disease News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Parkinson's Disease Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »